Ehave Announces Asset Purchase Agreement with Zyus
Hit enter to search or ESC to close
Products
ADHD
Company
Company Overview
Partners
Partnership Inquiries
Careers
Newsroom
Investors
Investor Overview
Press Releases
Company Information
SEC Filings
Stock Information
Corporate Governance
Contact
Products
ADHD
Company
Company Overview
Partners
Partnership Inquiries
Careers
Newsroom
Investors
Investor Overview
Press Releases
Company Information
SEC Filings
Stock Information
Corporate Governance
Contact
Press Releases
Menu
Overview
Press Releases
Company Information
Stock Information
SEC Filings
Corporate Governance
Recent Press Releases
Ehave Announces Asset Purchase Agreement with Zyus and Recapitalization Transactions
March 25, 2019
Ehave to Explore Strategic Alternatives
October 16, 2018
Ehave Leverages Cognitive Game Engine to Assess Cannabis Impairment
August 20, 2018
Ehave Provides Update on Companion Animal Informatics Platform to Include Use of Medical Cannabis
August 14, 2018
CHILD-BRIGHT Network and Ehave Start Enrollment for Cognitive Rehabilitation Trial for Children with ADHD, Autism, and Congenital Heart Disease
June 28, 2018
Aequus and Ehave Enter into Collaboration Agreement for Comprehensive Patient Data Management in Clinical Trials of Medical Cannabis
March 5, 2018
Revive Therapeutics and Ehave Enter into Patient Research Data Collaboration Agreement for Medical Cannabis Liver Disease Program
March 1, 2018
Ehave Enters Blockchain Market for Secure Access of Patient Data in Mental Healthcare and Medical Cannabis
February 15, 2018
Ehave Announces Private Placement Transactions to Raise up to CDN$3 Million
February 7, 2018
Ehave to Host Facebook Live Q&A Session for Shareholders
February 7, 2018
View all News and Insights
Browse by Year
2019
2018
2017
2016
Ehave Announces Asset Purchase Agreement with Zyus
Products
ADHD
Company
Company Overview
Partners
Partnership Inquiries
Careers
Newsroom
Investors
Investor Overview
Press Releases
Company Information
SEC Filings
Stock Information
Corporate Governance
Contact